IntelligentMDx Gets Canadian ISO Certification | GenomeWeb

NEW YORK (GenomeWeb News) – IntelligentMDx today said that it has gained ISO certification from Canadian authorities to develop and manufacture its molecular diagnostic tests at its facilities in Cambridge , Mass., where the firm is based.

IMDx said that it underwent an audit of its quality system to ISO 13485:2003 with the implementation of requirements from the Canadian Medical Devices Regulations. The accreditation was received from the Laboratoire national de métrologie et d'essais and will enable the firm to seek licenses to commercialize its tests in Canada.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.